All News

The Food and Drug Administration approved chemotherapy injection Pemfexy for the treatment of patients with nonsquamous non-small cell lung cancer.

February is National Cancer Prevention Month; do you know your risk of hereditary cancer?

An optimistic attitude can prove effective in battling a cancer diagnosis, no matter who you are.

As interest grows in the use of cannabinoids for the management of cancer-related pain, a recent study shows that they do not provide a benefit in pain management for patients with advanced cancer using opioids.

A cancer survivor laments not getting more done until she realizes she just moves slower, and that's ok. As long as you don't stop.

Although most older women with breast cancer didn’t use the painkillers persistently, new study findings show women who received chemotherapy were at greater risk of new-onset persistent use.

Why reducing your risk matters right now — whether you or someone you love is in treatment or hoping to avoid a recurrence.

From actress Shannen Doherty announcing she will continue to fight her stage 4 breast cancer to the Food and Drug Administration’s first hearing on asbestos testing in talc in 50 years, here’s what is making headlines in the cancer space this week.

Patient Rod Gilmore shares his experience with multiple myeloma and the importance of creating a strategy to manage the disease.

The novel drug pairing of Venclexta and Gazyva, used for a fixed 12 months, is cost-effective compared with regimens that must be taken until disease progresses, a study finds.

Patients with stage 3 melanoma who had one or more circulating tumor cells were found to relapse sooner, providing physicians with an important biomarker to treat the likelihood of relapse.

Study findings showed that eradicating Helicobacter pylori infection reduced the risk of developing gastric cancer by 73% in those with a first-degree relative with the disease, compared with individuals in whom infection was persistent.

It's pretty clear that I have a lot of work ahead of me after years of devastation from cancer, but lately, I'm taking a new approach.

We asked our audience about the impact social media has had on their cancer journey, here's what they had to say.

Older survivors face increased symptom burden, which in turn affects their well-being, highlighting the need for cancer-related symptom surveillance and intervention.

The refinement of surgical treatment of cancer was named the American Society of Clinical Oncology’s advance of the year, according to its Annual Report on Progress Against Cancer.

Genetic cancer testing is a whole new world for cancer survivors, newly diagnosed patients with cancer and their family members.

The World Health Organization has announced a vaccination-based initiative to eliminate cervical cancer as a public health problem in low to middle income countries.

A new study supported the use of a blood test to detect clusters of cancer cells in the blood of asymptomatic individuals, meaning, patients could have a non-invasive screening and testing method.

The Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare disease organizations, including rare cancer foundations, to receive the first CZI Rare As One Network grant.

Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer.

Top Translational Grants Named for Former CEO Nick Valvano, Former Scientific Advisory Committee Chair Dr. Robert Bast.

Disparities exist around the globe when it comes to understanding cancer risk factors and prevention measures.

There can be advantages to participating in a wellness program with your insurance company.

When you discover you have pancreatic cancer, your first inclination may be to hit the web. Here's some strategies to navigate the information overload.

For World Cancer Day, here are 6 hot topics making an impact in the cancer space.

New research examining Surveillance, Epidemiology, and End Results (SEER) program data found that relying solely on this data may lead to underestimating the rising rate of colorectal cancer in patients aged 49 and 50.

One cancer survivor looks back on how a breast cancer diagnosis divided her life into a before and after, and looks ahead to what comes next.

Patients with head and neck paragangliomas, a rare neuroendocrine tumor type, may be safely and effectively treated with proton therapy.